PerkinElmer, Transgenomic sales and marketing update

Transgenomic granted PerkinElmer non-exclusive rights to commercialize Transgenomic's molecular diagnostic cancer products for use on PerkinElmer's LabChip MultiDx platform outside the U.S., effective Jan. 1, 2014. The companies declined to disclose details. ...